Diabetes patients in the US will now be able to purchase Ozempic for half its usual cost.
Novo Nordisk, a Danish pharmaceutical company, said on Monday that it would be providing the drug through its direct pharmacy service for $499 (£369) per month, instead of just under $1,000 per month.